¼¼°èÀÇ ¿¡¾î·ÎÁ¹ Àü´Þ ±â±â ½ÃÀå º¸°í¼­(2025³â)
Aerosol Delivery Devices Global Market Report 2025
»óǰÄÚµå : 1702695
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,108,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,914,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿¡¾î·ÎÁ¹ Àü´Þ ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¸¸¼º Áúȯ °ü¸® ¾ÖÇø®ÄÉÀÌ¼Ç È®´ë, R&D ÅõÀÚ Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, È£Èí±â ÁúȯÀ» À¯¹ßÇÏ´Â ´ë±â ¿À¿° ¼öÁØ Áõ°¡, È£Èí±â Ä¡·á ¼ö¿ä¸¦ °ßÀÎÇÏ´Â Àα¸ °í·ÉÈ­ µî¿¡ ±âÀÎÇÕ´Ï´Ù.

È£Èí±â ÁúȯÀÇ ¹ß»ý·ü Áõ°¡´Â ¿¡¾î·ÎÁ¹ Àü´Þ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °³¼± ¹× È£Èí±â ÁúȯÀÇ Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. 2024³â 5¿ù ¹Ì±¹ ±¹¸³º¸°ÇÅë°è¼¾ÅÍ(NCHS)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¹Ì±¹ ¼ºÀÎÀÇ Ãµ½Ä À¯º´·üÀº 2021³â 8%¿¡¼­ 2022³â 8.7%·Î Áõ°¡ÇßÀ¸¸ç, °°Àº ±â°£ µ¿¾È õ½Ä ¹ßº´·üµµ 3.3%¿¡¼­ 3.7%·Î Áõ°¡Çß½À´Ï´Ù. ±× °á°ú, È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¿¡¾î·ÎÁ¹ Àü´Þ ±â±â ½ÃÀåÀ» ÀüÁø½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¡¾î·ÎÁ¹ Àü´Þ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀÎÀ» ÅëÇØ ÀǾàǰ º¸ÃæÀ» Çâ»ó½Ã۱â À§ÇØ Çõ½ÅÀûÀÎ ÈíÀÔ ¿ë·® ÃßÀû±â °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¸®Á¨Æ® Æ®·¡Ä¿´Â ½Ç½Ã°£À¸·Î ÀǾàǰ »ç¿ëÀ» ¸ð´ÏÅ͸µÇϰí ÀǾàǰ º¸ÇèÀ» °³¼±Çϸç ȯÀÚ¿Í °Ç°­ °ü¸® Á¦°ø¾÷ü¿¡°Ô Á¾ÇÕÀûÀÎ µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 6¿ù, ¿µ±¹¿¡ º»»ç¸¦ µÐ ÀÇ·á ±â¼ú ȸ»çÀÎ Aseptika´Â ´Ù¾çÇÑ ÈíÀÔ±â¿Í ȣȯµÇ´Â ¼±±¸ÀûÀÎ ½º¸¶Æ® ÈíÀԱ⠿뷮 Ä«¿îÅÍÀÎ PUFFClicker3 À¯´Ï¹ö¼³ ÈíÀԱ⸦ Ãâ½ÃÇß½À´Ï´Ù. PUFFClicker3 À¯´Ï¹ö¼³ ÈíÀÔ±â´Â ´Ù¾çÇÑ ÈíÀÔ±â¿Í ȣȯµÇ´Â ¼±±¸ÀûÀÎ ½º¸¶Æ® ÈíÀÔ±â Åõ¿© Ä«¿îÅÍÀÌ¸ç °¢ º¹¿ë·®À» ±â·ÏÇÏ´Â ¼¾¼­¸¦ ä¿ëÇÏ¿© ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» Á¦°øÇÏ¸ç ¶Ù¾î³­ ÀÎÅÍÆäÀ̽º¸¦ °®Ãá ºí·çÅõ½º ¿¬°áÀ» ÅëÇØ °Ç°­ ¾Û°ú µ¿±âÈ­µË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°, ±×¸®°í °æ±â ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã °æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Aerosol delivery devices are specialized medical tools designed to administer medication as a mist or aerosol directly into the lungs. These devices are essential for treating respiratory conditions by precisely delivering therapeutic agents. Their primary goal is to ensure the effective and targeted distribution of medication within the respiratory system.

There are several types of aerosol delivery devices available, including dry powder inhalers, measured-dose inhalers, and nebulizers. Dry powder inhalers release medication in a powdered form, activated by the user's breath, and are utilized for conditions such as asthma, chronic obstructive pulmonary disease, cystic fibrosis, and other non-respiratory ailments. These devices are typically distributed through retail pharmacies, hospital pharmacies, and e-commerce platforms.

The aerosol delivery devices market research report is one of a series of new reports from the business research company that provides aerosol delivery devices market statistics, including aerosol delivery devices industry global market size, regional shares, competitors with an aerosol delivery devices market share, detailed aerosol delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the aerosol delivery devices industry. This aerosol delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aerosol delivery devices market size has grown strongly in recent years. It will grow from $47.6 billion in 2024 to $51.63 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases, regulatory approvals, growing adoption of portable devices, rising healthcare expenditure, increasing awareness campaigns about respiratory health, government initiatives, and funding.

The aerosol delivery devices market size is expected to see strong growth in the next few years. It will grow to $70.79 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to expanding applications in chronic disease management, increasing R&D investments, rising demand for personalized medicine, rising air pollution levels leading to respiratory disorders, and aging population driving demand for respiratory treatments. Major trends in the forecast period include technological advancements, advancements in drug delivery systems, the introduction of generic alternatives, the development of biologics and specialty drugs for inhalation therapy, and advancements in nanotechnology for aerosol drug delivery.

The rising incidence of respiratory diseases is anticipated to drive growth in the aerosol delivery device market. These diseases encompass various conditions affecting the airways, lungs, and respiratory system, attributed to factors such as air pollution, smoking, allergens, and respiratory infections. Aerosol delivery devices play a crucial role in treating respiratory diseases by efficiently administering medications such as bronchodilators and corticosteroids directly to the lungs, thereby enhancing therapeutic outcomes and patient compliance. According to data from the National Center for Health Statistics (NCHS) in May 2024, the prevalence of current asthma among adults in the United States increased from 8% in 2021 to 8.7% in 2022, with a corresponding rise in asthma episodes from 3.3% to 3.7% within the same period. Consequently, the growing prevalence of respiratory diseases is expected to propel the aerosol delivery device market forward.

Key players in the aerosol delivery device market are concentrating on developing innovative inhaler dose trackers to enhance medication adherence through user-friendly designs. These intelligent trackers, equipped with sensors and connectivity features, monitor medication usage in real-time, improving adherence and providing comprehensive data to patients and healthcare providers. For instance, in June 2024, Aseptika Ltd., a UK-based MedTech company, introduced the PUFFClicker3 Universal Inhaler, a pioneering smart inhaler dose counter compatible with various inhalers. It employs sensors to record each dose, offers real-time monitoring, features a user-friendly interface, and utilizes Bluetooth connectivity to sync with health apps. This innovation assists patients in adhering to medication schedules while equipping healthcare providers with valuable adherence information.

In January 2024, Kindeva Drug Delivery, a pharmaceutical company based in the United States, acquired Summit Biosciences Inc. for an undisclosed sum. This acquisition is intended to broaden Kindeva's portfolio in drug delivery technologies, with a specific focus on sterile drug products and nasal spray devices. By integrating Summit Biosciences, Kindeva aims to strengthen its market position and enhance its technological capabilities in these specialized areas. Summit Biosciences Inc., also based in the US, specializes in manufacturing aerosol delivery devices, including nasal sprays.

Major companies operating in the aerosol delivery devices market are Pfizer Inc, Merck & Co Inc, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc (GSK), 3M Company, Becton Dickinson and Company, Koninklijke Philips NV, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Draegerwerk AG & Co KGaA, Shionogi & Co Ltd, Hikma Pharmaceuticals PLC, Chiesi Farmaceutici SpA, Vectura Group plc, Fresenius Kabi AG, Metall Zug AG, Sunovion Pharmaceuticals Inc., Omron Healthcare, Inc., PARI GmbH, Aerogen Inc, Clement Clarke International Ltd, Iconovo AB

North America was the largest region in the aerosol delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aerosol delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aerosol delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aerosol delivery devices market consists of sales of soft mist inhalers, spacer devices, breath-actuated inhalers, and topical spray bottles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aerosol Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aerosol delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for aerosol delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aerosol delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Aerosol Delivery Devices Market Characteristics

3. Aerosol Delivery Devices Market Trends And Strategies

4. Aerosol Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Aerosol Delivery Devices Growth Analysis And Strategic Analysis Framework

6. Aerosol Delivery Devices Market Segmentation

7. Aerosol Delivery Devices Market Regional And Country Analysis

8. Asia-Pacific Aerosol Delivery Devices Market

9. China Aerosol Delivery Devices Market

10. India Aerosol Delivery Devices Market

11. Japan Aerosol Delivery Devices Market

12. Australia Aerosol Delivery Devices Market

13. Indonesia Aerosol Delivery Devices Market

14. South Korea Aerosol Delivery Devices Market

15. Western Europe Aerosol Delivery Devices Market

16. UK Aerosol Delivery Devices Market

17. Germany Aerosol Delivery Devices Market

18. France Aerosol Delivery Devices Market

19. Italy Aerosol Delivery Devices Market

20. Spain Aerosol Delivery Devices Market

21. Eastern Europe Aerosol Delivery Devices Market

22. Russia Aerosol Delivery Devices Market

23. North America Aerosol Delivery Devices Market

24. USA Aerosol Delivery Devices Market

25. Canada Aerosol Delivery Devices Market

26. South America Aerosol Delivery Devices Market

27. Brazil Aerosol Delivery Devices Market

28. Middle East Aerosol Delivery Devices Market

29. Africa Aerosol Delivery Devices Market

30. Aerosol Delivery Devices Market Competitive Landscape And Company Profiles

31. Aerosol Delivery Devices Market Other Major And Innovative Companies

32. Global Aerosol Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aerosol Delivery Devices Market

34. Recent Developments In The Aerosol Delivery Devices Market

35. Aerosol Delivery Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â